Preemptive genotyping

56 %
44 %
Information about Preemptive genotyping
Health & Medicine

Published on March 14, 2014

Author: sherifmohamedelrefai

Source: slideshare.net

Description

Sherif El Refai - Today's status of preemptive genotyping

Sherif El Refai

 As big as the subject of Pharmacogenomics is these days, there is still one major hurdle it has yet to surpass – will the burden of cost and time ever be less than the potential benefits achieved from full scale genotyping of patients? The Pharmacogenomic Quandary

 Of all the universities studying this topic, Vanderbilt has implemented a full scale service, the PREDICT program, that genotypes any patient with a history of coronary artery stent or has a >40% chance of receiving clopidogrel, warfarin or a statin in the next three years. Vanderbilt PREDICT Vanderbilt University Practice

 Sherif El Refai is currently researching pharmacogenomics & individualized therapy at the UNC Eshelman School of Pharmacy. UNC CPIT Conclusion

Add a comment

Related presentations

Related pages

Preemptive Genotyping and Pain Management - Full Text View ...

Primary Outcome Measures: Feasibility of PreEmptive Genotyping Testing [ Time Frame: From initial clinic visit to post-operative discharge, expected ...
Read more

Preemptive Genotyping for Personalized Medicine ...

Preemptive Genotyping for Personalized Medicine: DesignoftheRightDrug,RightDose,RightTimedUsing Genomic Data to Individualize Treatment Protocol
Read more

The New Landscape of Pharmacogenetics

For preemptive genotyping to be widely deployed, the structure of electronic health records (EHRs) will need to evolve so that they enable the retrieval, ...
Read more

preemptive genotyping (PG). | Patients Talk...

Posts about preemptive genotyping (PG). written by tanyaznamenskaya
Read more